Renal news roundup from AKF

Travere Therapeutics has secured Food and Drug Administration (FDA) approval for sparsentan (Filspari), the first therapy for focal segmental glomerulosclerosis (FSGS). The approval is for reduction in proteinuria in adult and children aged 8 and older with FSGS without nephrotic...

A post-approval trial has confirmed the efficacy of Medtronic's IN.PACT AV drug-coated balloon for patients with end-stage kidney disease (ESKD). The trial found that 70.2% of lesions remained open 12 months without treatment, compared with 65.3% with treatment in the original pi...

DaVita Kidney Care's AI tool for home dialysis patients, the Peritoneal Dialysis Loss Model, identifies risks by analyzing extensive data, enabling timely interventions. This approach helps maintain patients on home dialysis longer, reducing the need for in-center treatment. Jeff...

A behavioral intervention involving a Bluetooth-enabled smart water bottle designed to prompt increased fluid intake did not significantly reduce kidney stone recurrence, but did increase 24-hour urine output, according to a study in The Lancet. The study involved 1,658 participa...

Current guidelines for treating fungal contamination in organ preservation fluid may lead to overtreatment, particularly in kidney transplant recipients, according to a study presented at the Society for Healthcare Epidemiology of America Spring conference. The research found tha...

An analysis of the SURPASS-CVOT study, published in JAMA Cardiology, shows that tirzepatide offers more extensive cardiorenal protection than dulaglutide in individuals with type 2 diabetes and cardiovascular disease. The study found that tirzepatide significantly reduces a compo...

The M1 genetic variant might protect individuals with high-risk APOL1-mediated kidney disease (AMKD), particularly those of Black African ancestry, according to a study published in JAMA Network Open. Researchers found that M1 significantly reduces the risk of kidney disease in i...

Surgeon Joshua Mezrich explains the potential of xenotransplantation to address the organ shortage crisis. Mezrich notes that genetically modified pig organs are already being used in clinical trials, and he predicts that advancements in gene editing will make pig organs comparab...

Father Raymund Reyes, pastor at St. Augustine Parish in South San Francisco, received a life-changing living donor kidney transplant from his friend, Father Francis Garbo, in January 2026. The procedure was performed at Sutter Health's California Pacific Medical Center, which is ...